These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22336206)

  • 1. [Loss of pan-T cell antigens CD2, CD3, CD5 and CD7 in Kikuchi's disease].
    Wei XJ; Xie JL; Zhou XG; Zheng XD; Zheng YY; Jin Y; Zhu H; Zhang YN; Zhang SH; Chen GY
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):815-9. PubMed ID: 22336206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant phenotypes in Kikuchi's disease.
    Wei XJ; Zhou XG; Xie JL; Zheng XD; Zheng YY
    Int J Clin Exp Pathol; 2014; 7(9):5557-63. PubMed ID: 25337197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lineage determination of CD7+ CD5- CD2- and CD7+ CD5+ CD2- lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3 epsilon, and CD3 delta.
    Yoneda N; Tatsumi E; Teshigawara K; Nagata S; Nagano T; Kishimoto Y; Kimura T; Yasunaga K; Yamaguchi N
    Am J Hematol; 1994 Apr; 45(4):310-20. PubMed ID: 7513945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of CD123 in histiocytic necrotizing lymphadenitis].
    Wei X; Zhou X; Xie J; Zheng X; Zheng Y
    Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):680-4. PubMed ID: 25567595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression pattern of CD45 RA/RO isoformic antigens in T-lineage neoplasms.
    Kawano S; Tatsumi E; Yoneda N; Tani A; Nakamura F
    Am J Hematol; 1995 May; 49(1):6-14. PubMed ID: 7741140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of T cell antigens in normal peripheral blood lymphocytes: a quantitative analysis by flow cytometry.
    Ginaldi L; Farahat N; Matutes E; De Martinis M; Morilla R; Catovsky D
    J Clin Pathol; 1996 Jul; 49(7):539-44. PubMed ID: 8813949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD2 and CD3 associate independently with CD5 and differentially regulate signaling through CD5 in Jurkat T cells.
    Carmo AM; Castro MA; Arosa FA
    J Immunol; 1999 Oct; 163(8):4238-45. PubMed ID: 10510361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cutaneous lesions of Kikuchi's disease: a comprehensive analysis of 16 cases based on the clinicopathologic, immunohistochemical, and immunofluorescence studies with an emphasis on the differential diagnosis.
    Kim JH; Kim YB; In SI; Kim YC; Han JH
    Hum Pathol; 2010 Sep; 41(9):1245-54. PubMed ID: 20434191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histiocytic necrotizing lymphadenitis (Kikuchi's disease): in situ end-labeling, immunohistochemical, and serologic evidence supporting cytotoxic lymphocyte-mediated apoptotic cell death.
    Felgar RE; Furth EE; Wasik MA; Gluckman SJ; Salhany KE
    Mod Pathol; 1997 Mar; 10(3):231-41. PubMed ID: 9071731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
    Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
    Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasonographic differentiation between Kikuchi's disease and lymphoma in patients with cervical lymphadenopathy.
    Lo WC; Chang WC; Lin YC; Hsu YP; Liao LJ
    Eur J Radiol; 2012 Aug; 81(8):1817-20. PubMed ID: 21546181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentations, laboratory results and outcomes of patients with Kikuchi's disease: emphasis on the association between recurrent Kikuchi's disease and autoimmune diseases.
    Cheng CY; Sheng WH; Lo YC; Chung CS; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2010 Oct; 43(5):366-71. PubMed ID: 21075702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD21 antigen in T-lineage neoplastic lymphoid cells: characteristic expression at thymic stage.
    Tatsumi E; Yoneda N; Kawano S; Yamaguchi N
    Am J Hematol; 1994 Feb; 45(2):150-5. PubMed ID: 7511331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Eyelid edema revealing Kikuchi's disease].
    Roger M; Hopfner C; Loiselet G; Libbrecht E; Bressieux JM; Fur A
    Ann Dermatol Venereol; 1999 Nov; 126(11):826-8. PubMed ID: 10612861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kikuchi's disease (histiocytic necrotizing lymphadenitis). A clinicopathologic study of 79 cases with an analysis of histologic subtypes, immunohistology, and DNA ploidy.
    Kuo TT
    Am J Surg Pathol; 1995 Jul; 19(7):798-809. PubMed ID: 7793478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome and predictive factors of recurrence among patients with Kikuchi's disease.
    Song JY; Lee J; Park DW; Sohn JW; Suh SI; Kim IS; Kim WJ; Kim MJ; Cheong HJ
    Int J Infect Dis; 2009 May; 13(3):322-6. PubMed ID: 19208493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD3 gamma, CD3 delta, and CD3 zeta mRNA in adult human marrow hematopoietic progenitors correlates with surface CD2 and CD7 expression.
    Long H; Gaffney P; Mortari F; Miller JS
    Exp Hematol; 1996 Oct; 24(12):1402-8. PubMed ID: 8913286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Kikuchi's disease using glucocorticoid.
    Jang YJ; Park KH; Seok HJ
    J Laryngol Otol; 2000 Sep; 114(9):709-11. PubMed ID: 11091837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kikuchi's disease (histiocytic necrotizing lymphadenitis): report of one case.
    Lien CH; Yang W; Tsai YC; Huang PH
    Acta Paediatr Taiwan; 1999; 40(5):344-7. PubMed ID: 10910547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.